EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Methylene blue retains in vitro activity against early ring-stage artemisinin-resistant Plasmodium falciparum

Olivia Verdier, Peter Christensen, Chalita Kaewkanya, Pachinee Kobphan, Candy Beau, Aung Pyae Phyo, Mallika Imwong, Kesinee Chotivanich, Nicholas J White, François Nosten, Victor Chaumeau

Malaria Journal · 2026-05-05 · 25 (1)

DOI: 10.1186/s12936-026-05928-7 ↗

At a glance

Journal article in Malaria Journal, published online on 2026-05-05. Written by Olivia Verdier and 10 co-authors. Institution: Shoklo Malaria Research Unit, Faculty of Tropical Medicine, Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Mae Ramat, Thailand. Major MEDLINE topics: Methylene Blue, Plasmodium falciparum, Antimalarials, Artemisinins. 37 references. The full text is freely available (open access, CC BY 4.0). Funded by: Wellcome Trust, Wellcome.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Artemisinin resistance in Plasmodium falciparum is now well established in three continents and challenges the efficacy of antimalarial drug regimens. This study examined whether methylene blue, an ancient antimalarial drug with a broad spectrum of activity against Plasmodium blood stages, retains its activity against the young rings of artemisinin-resistant parasites. Clinical isolates carrying kelch13 wild type (n = 3), R561H (n = 9), or P441L (n = 10) genotypes were tested with a modified ring survival assay whereby 0- to 3-h post-invasion rings were exposed to a range of methylene blue concentrations. Ring survival was analysed with a Bayesian mixed effects E max model accounting for variability across isolates and experimental replicates. Methylene blue suppressed ring-stage survival at low nanomolar concentrations with no evidence of kelch13 -mediated cross-resistance: the mean 50% inhibitory concentration (IC 50 ) estimates were 23 nM (95% credible interval [CrI]: 15 to 37) for wild type, 27 nM (95% CrI: 21 to 36) for R561H and 14 nM (95% CrI: 10 to 20) for P441L. These findings indicate that methylene blue remains active in vitro against ring-stage artemisinin-resistant parasites.

Subjects

MeSH terms (MEDLINE)

Methylene BluePlasmodium falciparumAntimalarialsArtemisininsDrug ResistanceHumansInhibitory Concentration 50Parasitic Sensitivity Tests

Author keywords

Plasmodium falciparumkelch13Artemisinin resistanceEmax modelIn vitro sensitivityMethylene blueP441LR561HRing survival assayThailand-Myanmar border

Substances

Methylene BlueAntimalarialsArtemisininsartemisinin

Authors and institutions

  • Shoklo Malaria Research Unit, Faculty of Tropical Medicine, Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Mae Ramat, Thailand.
  • Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
  • Department of Molecular Tropical Medicine and Genetics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
  • Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
  • Shoklo Malaria Research Unit, Faculty of Tropical Medicine, Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Mae Ramat, Thailand. victor@tropmedres.ac.

Funding

  • Wellcome Trust
  • Wellcome

Cite

APA

Verdier, O., Christensen, P., Kaewkanya, C., Kobphan, P., Beau, C., Phyo, A. P., Imwong, M., Chotivanich, K., White, N. J., Nosten, F., & Chaumeau, V. (2026). Methylene blue retains in vitro activity against early ring-stage artemisinin-resistant Plasmodium falciparum. Malaria Journal, 25(1). https://doi.org/10.1186/s12936-026-05928-7

Vancouver

Verdier O, Christensen P, Kaewkanya C, Kobphan P, Beau C, Phyo AP, et al. Methylene blue retains in vitro activity against early ring-stage artemisinin-resistant Plasmodium falciparum. Malaria Journal. 2026;25(1). doi:10.1186/s12936-026-05928-7

BibTeX
@article{Verdier2026,
  author = {Verdier, Olivia and Christensen, Peter and Kaewkanya, Chalita and Kobphan, Pachinee and Beau, Candy and Phyo, Aung Pyae and Imwong, Mallika and Chotivanich, Kesinee and White, Nicholas J and Nosten, François and Chaumeau, Victor},
  title = {Methylene blue retains in vitro activity against early ring-stage artemisinin-resistant Plasmodium falciparum},
  journal = {Malaria Journal},
  year = {2026},
  volume = {25},
  number = {1},
  doi = {10.1186/s12936-026-05928-7}
}
Start for free →